Intrinsiqq
Bayer AG logo

Bayer AG Quality Score

BAYN.XETR

⊜ Compare
Quality32

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
0/100
-30.9x

Negative earnings, no valuation support

Cash Flow Multiple
60/100
25.6x

25–30x, paying up for cash generation

Revenue Growth
0/100
-2.8%

Below 2%, essentially flat

Cash Flow Growth
0/100
-15.8%

Below 2%, essentially flat

Business Quality & Capital Allocation

Share Dilution
80/100
0.0%

Roughly flat, no meaningful dilution

Margin Trend
100/100
+3.5pp

Expanded 3+pp, strong improvement

Capital Structure
0/100
€28.60B

Net debt/FCF of 13.8x, high leverage

2022
€10.2B
€41.3B
2023
€10.6B
€42.9B
2024
€8.09B
€40.7B
2025
€7.86B
€36.5B
CashDebt
Return on Capital
0/100
7.2%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

Bayer (BAYN.XETR) quality: score, margins and returns

Bayer (BAYN.XETR) scores 32/100 on Intrinsiqq's quality score (a lower-quality business), a weighted blend of 7 metrics each scored 0 to 100, on 18.0% operating margins and 7.2% ROIC. Every metric is computed from company filings; this is analysis, not investment advice.

Frequently asked

Is Bayer (BAYN.XETR) a high-quality business?+

Bayer scores 32 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which rates it a lower-quality business on these measures. Recent figures include a 18.0% operating margin and a 7.2% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Bayer's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from BAYN.XETR's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Bayer scores well and where it falls behind.

What is Bayer's return on invested capital (ROIC)?+

Bayer earns about 7.2% on its invested capital, which is modest. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to BAYN.XETR's margins and growth on this scorecard to judge durability.

How profitable is Bayer?+

Bayer runs an operating margin of about 18.0% and a net margin of about -3.8%. Revenue has grown at roughly 0.8% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from company filings, not investment advice.

More on BAYN.XETR: Overview · DCF valuation · Dividend safety · Financials
How the market compares: US profitability statistics

Peers

Drug Manufacturers - General · Pick stocks to compare with BAYN.XETR

CompareIntrinsic value
SHL.XETRSiemens Healthineers AG
€44.85+3.46%65
001360.XKRXSamsung Pharmaceutical Co., Ltd.
₩1,262.00+2.94%0
0010V0.XKRXJPI Healthcare Co., Ltd.
₩7,650.00-2.05%56
NOVN.XSWXNovartis AG Registered Shares
CHF 128.78+1.02%82
GSK.XLONGSK plc
£18.92+3.53%46
SBMFFSino Biopharmaceutical Limited
$0.67+0.00%74
002630.XKRXOrientbio Inc.
₩1,197.00+1.96%26
AZN.XLONAstraZeneca PLC
£140.32+1.98%56

Held by ETFs

BAYN.XETR is in 135 US ETFs. The largest of them, with BAYN.XETR's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing BAYN.XETR

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.